Cite
Pichiorri F, Palmieri D, De Luca L, et al. Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. J Exp Med. 2017;214(5):1557doi: 10.1084/jem.2012095001172017c.
Pichiorri, F., Palmieri, D., De Luca, L., Consiglio, J., You, J., Rocci, A., Talabere, T., Piovan, C., Lagana, A., Cascione, L., Guan, J., Gasparini, P., Balatti, V., Nuovo, G., Coppola, V., Hofmeister, C. C., Marcucci, G., Byrd, J. C., Volinia, S., Shapiro, C. L., Freitas, M. A., & Croce, C. M. (2017). Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. The Journal of experimental medicine, 214(5), 1557. https://doi.org/10.1084/jem.2012095001172017c
Pichiorri, Flavia, et al. "Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation." The Journal of experimental medicine vol. 214,5 (2017): 1557. doi: https://doi.org/10.1084/jem.2012095001172017c
Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan J, Gasparini P, Balatti V, Nuovo G, Coppola V, Hofmeister CC, Marcucci G, Byrd JC, Volinia S, Shapiro CL, Freitas MA, Croce CM. Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. J Exp Med. 2017 May 01;214(5):1557. doi: 10.1084/jem.2012095001172017c. Epub 2017 Jan 19. PMID: 28104811; PMCID: PMC5413319.
Copy
Download .nbib